The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AbCellera Biologics Inc. | COM | 00288U106 | 354,888 | 10,450,180 | SH | SOLE | 10,450,180 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 1,081,296 | 41,910,704 | SH | SOLE | 41,910,704 | 0 | 0 | ||
Acceleron Pharma Inc. | COM | 00434H108 | 3,042 | 22,430 | SH | SOLE | 22,430 | 0 | 0 | ||
Achilles Therapeutics plc | SPONSORED ADS | 00449L102 | 42,887 | 2,591,366 | SH | SOLE | 2,591,366 | 0 | 0 | ||
Adamas Pharmaceuticals, Inc. | COM | 00548A106 | 710 | 147,996 | SH | SOLE | 147,996 | 0 | 0 | ||
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 52,202 | 9,830,877 | SH | SOLE | 9,830,877 | 0 | 0 | ||
ADC Therapeutics SA | SHS | H0036K147 | 34,616 | 1,418,107 | SH | SOLE | 1,418,107 | 0 | 0 | ||
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 27,008 | 3,410,106 | SH | SOLE | 3,410,106 | 0 | 0 | ||
Affimed N.V. | COM | N01045108 | 1,302 | 164,605 | SH | SOLE | 164,605 | 0 | 0 | ||
Akero Therapeutics, Inc. | COM | 00973Y108 | 3,434 | 118,378 | SH | SOLE | 118,378 | 0 | 0 | ||
Albireo Pharma, Inc. | COM | 01345P106 | 14,539 | 412,466 | SH | SOLE | 412,466 | 0 | 0 | ||
Alector, Inc. | COM | 014442107 | 4,818 | 239,228 | SH | SOLE | 239,228 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 610,617 | 3,993,312 | SH | SOLE | 3,993,312 | 0 | 0 | ||
Aligos Therapeutics, Inc. | COM | 01626L105 | 36,611 | 1,610,000 | SH | SOLE | 1,610,000 | 0 | 0 | ||
Alkermes plc | SHS | G01767105 | 22,942 | 1,228,170 | SH | SOLE | 1,228,170 | 0 | 0 | ||
Allakos Inc. | COM | 01671P100 | 80,696 | 703,050 | SH | SOLE | 703,050 | 0 | 0 | ||
Altimmune, Inc. | COM | 02155H200 | 38,978 | 2,758,518 | SH | SOLE | 2,758,518 | 0 | 0 | ||
Amarin Corporation plc | SPONSORED ADR | 023111206 | 164,276 | 26,453,422 | SH | SOLE | 26,453,422 | 0 | 0 | ||
AnaptysBio, Inc. | COM | 032724106 | 9,206 | 427,179 | SH | SOLE | 427,179 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc. | COM | 03753U106 | 71,832 | 1,674,004 | SH | SOLE | 1,674,004 | 0 | 0 | ||
argenx SE | SPONSORED ADR | 04016X101 | 308,315 | 1,119,557 | SH | SOLE | 1,119,557 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 456,270 | 3,540,270 | SH | SOLE | 3,540,270 | 0 | 0 | ||
Assembly Biosciences, Inc. | COM | 045396108 | 7,091 | 1,541,418 | SH | SOLE | 1,541,418 | 0 | 0 | ||
Atreca, Inc. | CL A COM | 04965G109 | 54,157 | 3,532,760 | SH | SOLE | 3,532,760 | 0 | 0 | ||
Athira Pharma, Inc. | COM | 04746L104 | 14,837 | 806,367 | SH | SOLE | 806,367 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | COM | 05156V102 | 18,310 | 1,410,064 | SH | SOLE | 1,410,064 | 0 | 0 | ||
Autolus Therapeutics plc | SPONSORED ADS | 05280R100 | 2,646 | 461,726 | SH | SOLE | 461,726 | 0 | 0 | ||
Axsome Therapeutics, Inc. | COM | 05464T104 | 35,581 | 628,414 | SH | SOLE | 628,414 | 0 | 0 | ||
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 4,061,710 | 11,668,897 | SH | SOLE | 11,668,897 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | COM | 079481404 | 937 | 249,123 | SH | SOLE | 249,123 | 0 | 0 | ||
BioAtla, Inc. | COM | 09077B104 | 41,943 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | ||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 129,269 | 12,710,818 | SH | SOLE | 12,710,818 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 573,068 | 7,589,294 | SH | SOLE | 7,589,294 | 0 | 0 | ||
bluebird bio, Inc. | COM | 09609G100 | 6,844 | 226,988 | SH | SOLE | 226,988 | 0 | 0 | ||
Burning Rock Biotech Limited | SPONSORED ADS | 12233L107 | 5,630 | 209,131 | SH | SOLE | 209,131 | 0 | 0 | ||
Cabaletta Bio, Inc. | COM | 12674W109 | 7,064 | 636,363 | SH | SOLE | 636,363 | 0 | 0 | ||
Cerus Corporation | COM | 157085101 | 82,416 | 13,713,195 | SH | SOLE | 13,713,195 | 0 | 0 | ||
ChemoCentryx, Inc. | COM | 16383L106 | 33,650 | 656,710 | SH | SOLE | 656,710 | 0 | 0 | ||
Chiasma, Inc. | COM | 16706W102 | 2,323 | 742,133 | SH | SOLE | 742,133 | 0 | 0 | ||
Chinook Therapeutics, Inc. | COM | 16961L106 | 11,635 | 748,693 | SH | SOLE | 748,693 | 0 | 0 | ||
Constellation Pharmaceuticals, Inc. | COM | 210373106 | 2,684 | 114,735 | SH | SOLE | 114,735 | 0 | 0 | ||
Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 9,420 | 616,520 | SH | SOLE | 616,520 | 0 | 0 | ||
Cymabay Therapeutics, Inc. | COM | 23257D103 | 9,854 | 2,170,464 | SH | SOLE | 2,170,464 | 0 | 0 | ||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 77,894 | 14,614,264 | SH | SOLE | 14,614,264 | 0 | 0 | ||
Denali Therapeutics Inc. | COM | 24823R105 | 5,067 | 88,738 | SH | SOLE | 88,738 | 0 | 0 | ||
Design Therapeutics, Inc. | COM | 25056L103 | 42,955 | 1,436,636 | SH | SOLE | 1,436,636 | 0 | 0 | ||
Edgewise Therapeutics, Inc. | COM | 28036F105 | 16,250 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
Evofem Biosciences, Inc. | COM | 30048L104 | 4,720 | 2,697,110 | SH | SOLE | 2,697,110 | 0 | 0 | ||
Frequency Therapeutics, Inc. | COM | 35803L108 | 528 | 55,555 | SH | SOLE | 55,555 | 0 | 0 | ||
Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | 56,737 | 2,024,876 | SH | SOLE | 2,024,876 | 0 | 0 | ||
Fulgent Genetics, Inc. | COM | 359664109 | 38,746 | 401,016 | SH | SOLE | 401,016 | 0 | 0 | ||
Galapagos NV | SPONSORED ADR | 36315X101 | 862 | 11,180 | SH | SOLE | 11,180 | 0 | 0 | ||
Galmed Pharmaceuticals Ltd. | SHS | M47238106 | 634 | 184,927 | SH | SOLE | 184,927 | 0 | 0 | ||
Gamida Cell Ltd. | SHS | M47364100 | 8,391 | 1,037,226 | SH | SOLE | 1,037,226 | 0 | 0 | ||
Genetron Holdings Limited | ADS | 37186H100 | 9,771 | 455,306 | SH | SOLE | 455,306 | 0 | 0 | ||
Genfit SA | ADS | 372279109 | 68 | 14,720 | SH | SOLE | 14,720 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | COM | 37890U108 | 131,111 | 3,217,441 | SH | SOLE | 3,217,441 | 0 | 0 | ||
Harmony Biosciences Holdings, Inc. | COM | 413197104 | 4,084 | 123,600 | SH | SOLE | 123,600 | 0 | 0 | ||
Heron Therapeutics, Inc. | COM | 427746102 | 97,174 | 5,994,704 | SH | SOLE | 5,994,704 | 0 | 0 | ||
HOOKIPA Pharma Inc. | COM | 43906K100 | 9,421 | 700,481 | SH | SOLE | 700,481 | 0 | 0 | ||
Horizon Therapeutics Public Ltd Co | SHS | G46188101 | 55,142 | 599,110 | SH | SOLE | 599,110 | 0 | 0 | ||
Idera Pharmaceuticals, Inc. | COM PAR | 45168K405 | 2,661 | 2,047,180 | SH | SOLE | 2,047,180 | 0 | 0 | ||
IGM Biosciences, Inc. | COM | 449585108 | 242,041 | 3,156,102 | SH | SOLE | 3,156,102 | 0 | 0 | ||
Immatics N.V. | SHS | N44445109 | 44,759 | 3,992,756 | SH | SOLE | 3,992,756 | 0 | 0 | ||
Immunocore Holdings plc | ADS | 45258D105 | 107,307 | 2,520,730 | SH | SOLE | 2,520,730 | 0 | 0 | ||
Incyte Corporation | COM | 45337C102 | 2,600,753 | 32,001,387 | SH | SOLE | 32,001,387 | 0 | 0 | ||
Inflarx N.V. | COM | N44821101 | 538 | 138,040 | SH | SOLE | 138,040 | 0 | 0 | ||
Instil Bio, Inc. | COM | 45783C101 | 97,654 | 3,893,700 | SH | SOLE | 3,893,700 | 0 | 0 | ||
Inozyme Pharma, Inc. | COM | 45790W108 | 2,119 | 106,999 | SH | SOLE | 106,999 | 0 | 0 | ||
Insmed Incorporated | COM PAR $.01 | 457669307 | 73,433 | 2,156,001 | SH | SOLE | 2,156,001 | 0 | 0 | ||
Invitae Corporation | COM | 46185L103 | 601,776 | 15,749,182 | SH | SOLE | 15,749,182 | 0 | 0 | ||
Iteos Therapeutics, Inc. | COM | 46565G104 | 5,139 | 150,346 | SH | SOLE | 150,346 | 0 | 0 | ||
IVERIC bio, Inc. | COM | 46583P102 | 8,689 | 1,406,037 | SH | SOLE | 1,406,037 | 0 | 0 | ||
Karuna Therapeutics, Inc. | COM | 48576A100 | 8,412 | 69,966 | SH | SOLE | 69,966 | 0 | 0 | ||
Kezar Life Sciences, Inc. | COM | 49372L100 | 832 | 139,676 | SH | SOLE | 139,676 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 51,820 | 2,799,577 | SH | SOLE | 2,799,577 | 0 | 0 | ||
Kymera Therapeutics, Inc. | COM | 501575104 | 76,135 | 1,959,211 | SH | SOLE | 1,959,211 | 0 | 0 | ||
Kodiak Sciences Inc. | COM | 50015M109 | 1,573,848 | 13,879,952 | SH | SOLE | 13,879,952 | 0 | 0 | ||
Krystal Biotech, Inc. | COM | 501147102 | 58,582 | 760,412 | SH | SOLE | 760,412 | 0 | 0 | ||
Leap Therapeutics, Inc. | COM | 52187K101 | 1,063 | 559,705 | SH | SOLE | 559,705 | 0 | 0 | ||
Legend Biotech Corporation | SPONSORED ADS | 52490G102 | 3,355 | 115,626 | SH | SOLE | 115,626 | 0 | 0 | ||
LogicBio Therapeutics, Inc. | COM | 54142F102 | 3,287 | 451,478 | SH | SOLE | 451,478 | 0 | 0 | ||
MacroGenics, Inc. | COM | 556099109 | 6,392 | 200,679 | SH | SOLE | 200,679 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 175,363 | 1,499,213 | SH | SOLE | 1,499,213 | 0 | 0 | ||
Mereo BioPharma Group plc | ADS | 589492107 | 22,646 | 6,719,948 | SH | SOLE | 6,719,948 | 0 | 0 | ||
Merus N.V. | COM | N5749R100 | 42,563 | 2,037,469 | SH | SOLE | 2,037,469 | 0 | 0 | ||
Mirati Therapeutics, Inc. | COM | 60468T105 | 241,496 | 1,409,784 | SH | SOLE | 1,409,784 | 0 | 0 | ||
Mirum Pharmaceuticals, Inc. | COM | 604749101 | 12,830 | 647,313 | SH | SOLE | 647,313 | 0 | 0 | ||
Molecular Templates, Inc. | COM | 608550109 | 1,689 | 133,833 | SH | SOLE | 133,833 | 0 | 0 | ||
Neoleukin Therapeutics, Inc. | COM | 64049K104 | 47,046 | 3,821,740 | SH | SOLE | 3,821,740 | 0 | 0 | ||
NexImmune, Inc. | COM | 65344D109 | 5,612 | 294,117 | SH | SOLE | 294,117 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | COM | 64125C109 | 65,836 | 676,975 | SH | SOLE | 676,975 | 0 | 0 | ||
NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 8,483 | 291,801 | SH | SOLE | 291,801 | 0 | 0 | ||
Novavax, Inc. | COM | 670002401 | 26,064 | 143,756 | SH | SOLE | 143,756 | 0 | 0 | ||
Nurix Therapeutics, Inc. | COM | 67080M103 | 76,297 | 2,454,082 | SH | SOLE | 2,454,082 | 0 | 0 | ||
Opthea Limited | SPONSORED ADS | 68386J208 | 31,664 | 3,308,705 | SH | SOLE | 3,308,705 | 0 | 0 | ||
Otonomy, Inc. | COM | 68906L105 | 18,411 | 7,220,074 | SH | SOLE | 7,220,074 | 0 | 0 | ||
Orchard Therapeutics plc | ADS | 68570P101 | 5,332 | 734,431 | SH | SOLE | 734,431 | 0 | 0 | ||
Oyster Point Pharma, Inc. | COM | 69242L106 | 1,123 | 61,424 | SH | SOLE | 61,424 | 0 | 0 | ||
Pacific Biosciences of California, Inc. | COM | 69404D108 | 106,658 | 3,201,972 | SH | SOLE | 3,201,972 | 0 | 0 | ||
Passage Bio, Inc. | COM | 702712100 | 4,114 | 235,362 | SH | SOLE | 235,362 | 0 | 0 | ||
Prelude Therapeutics Incorporated | COM | 74065P101 | 438,665 | 10,123,824 | SH | SOLE | 10,123,824 | 0 | 0 | ||
Protagonist Therapeutics, Inc. | COM | 74366E102 | 37,197 | 1,436,192 | SH | SOLE | 1,436,192 | 0 | 0 | ||
Protara Therapeutics, Inc. | COM STK | 74365U107 | 3,143 | 199,671 | SH | SOLE | 199,671 | 0 | 0 | ||
Reata Pharmaceuticals, Inc. | CL A | 75615P103 | 22,330 | 223,976 | SH | SOLE | 223,976 | 0 | 0 | ||
Replimune Group, Inc. | COM | 76029N106 | 4,684 | 153,512 | SH | SOLE | 153,512 | 0 | 0 | ||
Revolution Medicines, Inc. | COM | 76155X100 | 10,196 | 222,222 | SH | SOLE | 222,222 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 74,017 | 3,479,873 | SH | SOLE | 3,479,873 | 0 | 0 | ||
Sangamo Therapeutics, Inc. | COM | 800677106 | 5,376 | 429,063 | SH | SOLE | 429,063 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | COM | 803607100 | 4,375 | 58,700 | SH | SOLE | 58,700 | 0 | 0 | ||
Seagen Inc. | COM | 81181C104 | 6,564,018 | 47,270,759 | SH | SOLE | 47,270,759 | 0 | 0 | ||
Silverback Therapeutics, Inc. | COM | 82835W108 | 10,388 | 238,095 | SH | SOLE | 238,095 | 0 | 0 | ||
Syros Pharmaceuticals, Inc. | COM | 87184Q107 | 5,162 | 690,167 | SH | SOLE | 690,167 | 0 | 0 | ||
Talis Biomedical Corporation | COM | 87424L108 | 97,337 | 7,574,835 | SH | SOLE | 7,574,835 | 0 | 0 | ||
TCR2 Therapeutics Inc. | COM | 87808K106 | 3,896 | 176,461 | SH | SOLE | 176,461 | 0 | 0 | ||
Travere Therapeutics, Inc. | COM | 89422G107 | 4,667 | 186,915 | SH | SOLE | 186,915 | 0 | 0 | ||
Tricida, Inc. | COM | 89610F101 | 3,858 | 729,300 | SH | SOLE | 729,300 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 50,604 | 444,444 | SH | SOLE | 444,444 | 0 | 0 | ||
Verastem, Inc. | COM | 92337C104 | 42,038 | 17,019,294 | SH | SOLE | 17,019,294 | 0 | 0 | ||
Viking Therapeutics, Inc. | COM | 92686J106 | 2,302 | 363,980 | SH | SOLE | 363,980 | 0 | 0 | ||
Xencor, Inc. | COM | 98401F105 | 15,905 | 369,370 | SH | SOLE | 369,370 | 0 | 0 | ||
Xenon Pharmaceuticals Inc. | COM | 98420N105 | 13,454 | 751,639 | SH | SOLE | 751,639 | 0 | 0 | ||
Zymeworks Inc. | COM | 98985W102 | 53,954 | 1,708,472 | SH | SOLE | 1,708,472 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | NOTE 0.599% 8/1/2024 | 09061GAH4 | 15,299 | 15,000,000 | PRN | SOLE | 15,000,000 | 0 | 0 | ||
Invitae Corporation | NOTE 2.0% 9/1/2024 | 46185LAB9 | 15,557 | 10,300,000 | PRN | SOLE | 10,300,000 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | DBCV 1.5% 11/15/2024 | 803607AB6 | 11,970 | 9,174,000 | PRN | SOLE | 9,174,000 | 0 | 0 |